Search Within
Document Type
75-15-0
Applied Filters:
Keyword:'75-15-0'
Showing 1-30 of 1721 results for "75-15-0" within Technical Documents
PureFlex™ Plus Single-use Process Container Film
observed in the samples extracted at room temperature.1
0
15
30
45
60
75
1 7 30 60 90 120
0
15
30
Millistak+ activated carbon for mAb downstream purification
4.
0%
0 250 500 750 1000 1250
75%
100%
50%
25%
MAb Loading (mg/mL)
pH 5, 3.5 mS
pH 7, 3.5 mS
pH 5, 15 mS
pH 7, 15 mS
Pe
rc
en
t
PLA & PLGA Polymer Portfolio for Peptide & Small Molecule Formulation
COOH 0.25-0.35 15-40
EXPANSORB® DLG 65-6A 5.43122 PLGA 65/35 COOH 0.50-0.65 45-85
EXPANSORB® DLG 75-2A 5.43124 PLGA 75/25 COOH 0.08-0.21 5-20
EXPANSORB® DLG 75-5A 5.43125 PLGA 75/25 COOH 0.38-
White Paper: Accelerating Cell Line and Process Development
at
io
n
(
g
/L
)
Days
Clone F Titer
0 3 6 9 12 15 242118
• Advanced • Adv 75:25 4Feed • Adv 50:50 4Feed
Seed Train Intensification Using High Cell Density Cryopreservation
0 75 61 2 3 4
V
C
D
[
10
6
V
C
/m
L]
days
CHO K1
Expansion in Expansion Medium
Expansion in ExCEll® Advanced HD Perfusion Medium
0
25
20
Poster: Virus clearance using Eshmuno HCX
NaCl
75 mM NaCl
0 mM NaCl
300 mM NaCl
150 mM NaCl
75 mM NaCl
0 mM NaCl
300 mM NaCl
150 mM NaCl
75 mM NaCl
0 mM
Seed Train Intensification Using High Cell Density Cryopreservation and Specially-designed Expansion Medium
0 75 61 2 3 4
V
C
D
[
10
6
V
C
/m
L]
days
CHO K1
Expansion in Expansion Medium
Expansion in ExCEll® Advanced HD Perfusion Medium
0
25
20
Viscosity-Reducing Excipients for Protein Formulation
excipient.
0
60
40
20
80
100
Co
nt
ro
l
12
5
m
M
Ar
g
15
0
m
M
Om
12
5
m
M
Ph
e
15
0
m
M
Product Information Sheet-11417959001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Product Information Sheet-11417991001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
Product Information Sheet - 11417983001
100% 0 – 10% 50 – 75%
Bln I (Avr II) 25 – 50% 100% 25 – 50%
Dpn I 100% 75 – 100% 75 – 100%
Mae III 0 – 10% 10 – 25% 0 – 10%
Nde I 25 – 50% 100%
The Vmax Nomograph
0.0075
0.
10
0.
05
0
0.
02
5
0.
01
0
0.
00
50
0.
00
15
0.
00
07
5
0.
00
05
0.
00
03
5
0.
00
02
5
Product Information Sheet - 11082035001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Product Information Sheet - 11417967001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
Product Information Sheet - 11417975001
100
100
75–100
50–75
75–100
75–100
0–10
50–75
100
25–50
75–100
25–50
75–100
75-100
10–25
100
0–10
0–10
0–10
10–25
75–100
10–25
100
100
0–10
0–10
50–75
10–25
100
50–75
0–10
0–10
100
100
NovAseptic Mixer: High Shear In-Line Mixer Users guide, Technical Description, Installation, Operating Instructions, Maintenance
rotation (A) speed and rotor (E) speed.
15(36)
D
oc
um
en
t M
L-
0
75
The Effective Use of Protein Kinase Inhibitors
35
2
(1
0
µM
)
PD
9
80
59
(P
-2
15
) (
50
µ
M
)
SB
-2
03
58
0
(S
8
30
7)
(1
0
µM
A comparative study of hydrophobic and hydrophilic lubricants for optimal combination of galenical and dissolution properties
itraconazole.
Dissolution performace of itraconazole
1000 mL SGFsp pH 1.2; 75 rpm
Time [min]
5
1
2
3
4
0
0 15 30 45 60 75 90 105 120
Pure itraconazole Tablets with
User Guide TurboMix Bis Tris Gel Casting Kit
)
mPAGE® Combs
0 .75 mm, 10 wells 5 C75M10W
0 .75 mm, 15 wells 5 C75M15W
1 .0 mm, 10 wells 5 C1M10W
1 .0 mm, 15 wells 5 C1M15W
1 .5 mm, 10 wells
MixMate_Mixing-highly-viscous-liquids-Eppendorf-MixMate
20
0
µl
40
0
µl
30
0
µl
15
0
µl
W
or
ki
ng
v
ol
um
e:
2,
00
0
µl
1,
50
0
µl
2,
00
0
Single Pass Tangential Flow Filtraton (MS)
120%
18-20 g/L 1-sections
18-20 g/L 2-sections
18-20 g/L 3-sections
75 g/L 1-sections
75 g/L 2-sections
75 g/L 3-sections
C
on
ve
rs
io
n
Feed lpm/m2 total
N
W
P
(l
m
h/
PureFlex™and PureFlex™ Plus White Paper
acetone 67-64-1 10.0
Acetaldehyde (TIC) 75-07-0 51
water yes
acetone 67-64-1 75
tert-butyl alcohol 75-65-0 64
2-butanone 78-93-3 29
acetaldehyde (TIC) 75-07-0 188
Butanal (TIC) 123-72-8 58
Pentanal
Application Notes SeQuant®ZIC®-cHILIC Application Examples
Pressure drop: 39 Bar (566 psi)
85
95
35
45
55
65
75
In
te
ns
it
y
(m
AU
)
5
15
25
35
0
The Effective Use of Protein Kinase Inhibitors
35
2
(1
0
µM
)
PD
9
80
59
(P
-2
15
) (
50
µ
M
)
SB
-2
03
58
0
(S
8
30
7)
(1
0
µM
Enhancing the Solubility of Active Pharmaceutical Ingredients Using Hot Melt Extrusion and Polyvinyl Alcohol
formulation 30% drug load in 900 mL SGFsp;
paddle speed at 75 rpm, total runtime 120 minutes; n = 3.
0
Time [min]
30
20
10
0
15 30 45 60 75 90 105 120
Filtration of viscous / particle-laden samples using the Samplicity®Filtration System
2.1
B.
0
10
5
25
20
15
30
35
40
Fi
lt
ra
ti
on
t
im
e
(s
ec
.)
Conditioner Shampoo Liquid dish
detergent
Water
Mobius®Single-Use Technology Supporting ADC Processing
30
20
10
0
2 2.5 3 3.5 4 4.5 5 5.5 6 7 8 9 10 12 14 16 18 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95
Steam-in-Place Sterilization of Filtration Trains containing Milligard®PES Prefilters
sterilization.
0.0
20.0
40.0
60.0
80.0
100.0
120.0
140.0
0 605 10 15 20 25 30 35 40 45 50 55 65 70 75 80 85 90 95
T
em
Application Note- Mobius®Power MIX: Scalability in Mixing
liquid-liquid mixing time (at 75% volume) confirms the scalability relationship.
Figure 7. Scalability in mixing 1.5M NaCl in Mobius® Power MIX from 100 L to 2000 L.
0
5
10
15
20
100
Brochure: BIOshell Fused-Core® HPLC and UHPLC Columns for Biomolecule separation
efficiency.
0 5 10 15 20
0 2 4 6 8 10 12
0 5 10 15 20
0 2 4 6 8 10 12
Different Phase Chemistries Allows for Alternative Selectivity for Peptides
Page 1 of 58